๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Patterns of angiogenesis in nonsmall-cell lung carcinoma

โœ Scribed by Birgitte V. Offersen; Per Pfeiffer; Stephen Hamilton-Dutoit; Jens Overgaard


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
309 KB
Volume
91
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Patterns of practice survey for nonsmall
โœ Hak Choy; Yu Shyr; Anthony J. Cmelak; Peter J. Mohr; David H. Johnson ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 227 KB ๐Ÿ‘ 1 views

## BACKGROUND. Nonsmall cell lung carcinoma comprises approximately 75% of all lung carcinoma cases in the U.S. Newly evolving strategies have created considerable controversy regarding the optimal treatment for patients diagnosed with this disease. ## METHODS. A 17-item survey was designed to co

Thymidine phosphorylase activity in nons
โœ Tokujiro Yano; Sadanori Takeo ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 114 KB

BACKGROUND. This is the first study on the quantitative assessment of thymidine phosphorylase (TP) activity in patients with nonsmall lung carcinoma. TP is identical to the platelet-derived endothelial cell growth factor with its angiogenic activity. Thus, it is believed that TP activity in tumor ti

A comparison of patterns of care of nons
โœ Bruce E. Hillner; M. Kathleen McDonald; Christopher E. Desch; Thomas J. Smith; L ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 108 KB ๐Ÿ‘ 1 views

The objective of this study was to examine and compare lifetime treatment patterns and hospitalization of incident nonsmall cell lung carcinoma (NSCLC) between pre-Medicare eligible (age ฯฝ 65 years) and supplemental Medigap (age ี† 65 years) enrollees in a commercially insured cohort using insurance

Five-year survivors with resected PN2 no
โœ Motoyasu Sagawa; Akira Sakurada; Shigefumi Fujimura; Masami Sato; Satomi Takahas ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 59 KB

## Background: Some patients with resected pn2 lung carcinoma were long term survivors. to determine appropriate therapeutic modalities for the selected patients, the clinicopathologic characteristics of these patients were examined using the actual number of survivors rather than the cumulative su